A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes. - Shin, Sun-Hye; Kim, Hee-Yeon; Yoon, Hee-Soo; Park, Woo-Jae; Adams, David R.; Pyne, Nigel J.; Pyne, Susan; Park, Joo-Won (International Journal of Molecular Sciences, 2020)